SynthesisFrontiers in pharmacology2024

Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials.

Jingyue Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.